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Letter to the Editor 
Clinical Microbiology
Performance of Matrix-Assisted Laser Desorption 
Ionization Time-of-Fight Mass Spectrometry for Rapid 
Discrimination of Methicillin-Resistant Staphylococcus 
aureus (MRSA): First Report of a Relation Between 
Protein Peaks and MRSA spa Type
Soon Sung Kwon, M.D., Sung Kuk Hong, M.D., Myung Sook Kim, M.T., Dongeun Yong, M.D., and Kyungwon Lee, M.D. 
Department of Laboratory Medicine, Research Institute of Bacteria Resistance, Yonsei University College of Medicine, Seoul, Korea
Dear Editor,
Matrix-assisted laser desorption ionization-time of ﬂight mass 
spectrometry (MALDI-TOF MS) is widely applied for the rapid 
identification of bacterial species [1]. However, an antimicrobial 
susceptibility test (AST) should be performed by using conven-
tional methods following MALDI-TOF MS, and this delay repre-
sents a significant hurdle for the rapid adjustment of adminis-
tered antimicrobial treatments. To overcome this limitation, 
many methods to improve MALDI-TOF MS for the production of 
rapid AST results have been proposed [2–4]. For example, car-
bapenemase-producing Enterobacteriaceae can be detected by 
analyzing the MALDI-TOF MS peaks of carbapenems and their 
metabolites [2, 3]. 
Methicillin-resistant Staphylococcus aureus (MRSA) is one of 
the most important multidrug-resistant organism in hospital and 
community settings. To date, few studies have attempted to dif-
ferentiate MRSA and methicillin-susceptible S. aureus (MSSA) 
using MALDI-TOF MS. Despite the subsequent identification of 
many MRSA-specific peaks, no indisputable evidence has been 
obtained for reliable markers for MRSA and MSSA discrimina-
tion [5–7]. Furthermore, no study has evaluated Korean S. au-
reus isolates to date. Therefore, we aimed to identify MRSA iso-
lates in Korea using MALDI-TOF MS peak analysis, and evalu-
ated the feasibility of employing this method in clinical microbi-
ology laboratories.
This study was approved by institutional review board of Yon-
sei university health system (Approval number 4-2017-0456) 
and informed consent was waived due to the retrospective man-
ner of this study. We collected S. aureus isolated from the ante-
rior nares of patients with atopic dermatitis from 2012 to 2013. 
Of 81 isolates, 47 were MSSA and 34 were MRSA as confirmed 
by the cefoxitin disc diffusion test according to the CLSI docu-
ment M100-S25 [8]. All isolates were processed for protein ex-
traction by using Microflex LT (Bruker Daltonics GmbH, Bre-
men, Germany) according to the manufacturer protocol. In 
Phase 1, peptide profiles were analyzed by using the QuickClas-
sifier algorithm of ClinProTools 3.0 software (Bruker Daltonics 
GmbH). This model showed good sensitivity and specificity (Ta-
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ble 1). Using this high power of discrimination, we discovered 
peaks, which we called MRSA-specific peaks, at m/z 10,152 
and 5,070. These peaks were detected in 27 of the 34 (79.4%) 
MRSA isolates and were completely absent in all MSSA isolates. 
To validate these findings, we isolated S. aureus from blood cul-
tures referred in 2014 for Phase 2 of the study. Of the 92 S. au-
reus isolates, 54 were MRSA and 38 were MSSA. Although the 
same analysis was performed, the model showed a compara-
tively lower sensitivity and specificity than those from Phase 1 
isolates (Table 1). 
To evaluate whether the MRSA-specific peaks were associ-
ated with methicillin resistance in certain S. aureus clones, we 
determined the spa type of each S. aureus isolate as previously 
described [9]. The spa types of S. aureus isolates with MRSA-
specific peaks showed repeat profiles corresponding with those 
of spa complex VI [10]. Of the 92 isolates belonging to spa com-
plex VI, all MRSA isolates had MRSA-specific peaks (m/z 
10,152 and 5,070), while the MSSA isolates did not (Table 2). 
To establish the composition of the MRSA-specific peaks, we 
processed the protein data using ProteinPilot (AB SCIEX, Foster 
City, CA, USA), but could not match proteins to the peaks.  
Although several peptide spectra have been proposed to be 
useful for MRSA detection, the reliability of the MALDI-TOF MS 
result has been suggested to be problematic for this purpose. 
This controversy may come from differences in MALDI-TOF MS 
devices, matrix solutions, or even the different clones of each 
isolate among studies. To overcome these problems, we se-
lected a widely used device and used protein extraction meth-
ods to obtain spectra with high resolution. However, our results 
demonstrated that discrimination of MRSA is indeed difficult 
when using MALDI-TOF MS spectra. 
Although we failed to differentiate MRSA with comparable 
performance, our results show that a spa complex VI subset of 
MRSA could be correctly identified through the presence of 
MRSA-specific peaks. This finding supports the results of a pre-
vious study showing that MALDI-TOF MS-based identification of 
agr-positive MRSA was possible with high sensitivity and speci-
ficity [11]. In addition to the MRSA-specific peaks, we discov-
ered peaks of m/z 10,100 and 5,050 that only existed when the 
MRSA-specific peaks were absent. Alterations in peptides in-
volved in the mechanism of methicillin resistance are likely to 
explain this finding. 
The differentiation of MRSA using MALDI-TOF MS is not cur-
rently feasible. Nevertheless, we found MRSA-specific peaks 
that allowed the rapid identification of certain spa-type MRSA 
isolates with high predictability. To our knowledge, this is the 
first report of MALDI-TOF MS protein peaks detected only in 
MRSA while absent in MSSA in certain spa-type S. aureus iso-
lates. Further studies are required to establish the protein com-
position of these MRSA-specific peaks, preferred peptide prepa-
Table 1. Sensitivity and specificity of MALDI-TOF MS using ClinProTool for differentiating MRSA isolates in Phase 1 and Phase 2
Peak 
analysis 
method
Phase 1 Phase 2
Methicillin 
susceptibility SE (%) SP (%) PPV (%) NPV (%)
Methicillin 
susceptibility SE (%) SP (%) PPV (%) NPV (%)
Resistant Susceptible Resistant Susceptible
Resistant 33 3 97.1 
(82.9-99.8)
93.6 
(81.4-98.3)
91.7 
(76.4-97.8)
97.8 
(86.8-99.9)
34 12 63 
(48.7-75.4)
68.4 
(51.2-82.0)
73.9 
(58.6-85.2)
56.5 
(41.2-70.8)Susceptible 1 44 20 26
Abbreviations: MALDI-TOF MS, matrix-assisted laser desorption ionization-time of ﬂight mass spectrometry; MRSA, methicillin-resistant Staphylococcus aureus; 
SE, sensitivity; SP, specificity; PPV, positive-predictive value; NPV, negative-predictive value.       
Table 2. Diagnostic capability of MRSA-specific peaks in spa complex VI and other complexes 
Spa 
complex
MRSA-specific 
peaks
Phase 1 Phase 2
Methicillin susceptibility
SE (%) SP (%) PPV (%) NPV (%)
Methicillin susceptibility
SE (%) SP (%) PPV (%) NPV (%)
Resistant Susceptible Resistant Susceptible
VI + 27 0 100 100 100 100 21 0 100 100 100 100
  - 0 31         0 14        
Others + 0 0 0 100 0 69.6 0 0 0 100 0 42.1
  - 7 16         33 24      
Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; SE, sensitivity; SP, specificity; PPV, positive-predictive value; NPV, negative-predictive value.
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ration methods, and optimal analytic conditions.
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